Novo Nordisk’s Stock Went On A Crash Diet, And Investors Demonstrated Their Love For Oura
Manage episode 456817770 series 3598784
Novo Nordisk’s shares slimmed way down as investors felt disappointed by its latest obesity drug trial, while Oura raised $200 million from investors – proving it’s not just celebrities and executives who adore the Finnish smart rings.
Today’s stories:
141 επεισόδια